We use essential cookies to make our site work. With your consent, we may also use non-essential cookies to improve user experience, personalize content, customize advertisements, and analyze website traffic. For these reasons, we may share your site usage data with our social media, advertising, and analytics partners. By clicking ”Accept,” you agree to our website's cookie use as described in our Cookie Policy. You can change your cookie settings at any time by clicking “Preferences.”

TechDogs-"John Snow Labs Awarded Phase I SBIR Contract For The Development Of Medical Large Language Models For Infectious And Immune-Mediated Diseases"

Health Care Technology

John Snow Labs Awarded Phase I SBIR Contract For The Development Of Medical Large Language Models For Infectious And Immune-Mediated Diseases

GlobeNewswire
Overall Rating

Grant will fund R&D of LLMs for automated entity recognition, relation extraction, and ontology metadata enrichment from free-text clinical notes

LEWES, Del., Sept. 17, 2024 (GLOBE NEWSWIRE) -- John Snow Labs, the AI for healthcare company, today announced it has been awarded a Small Business Innovation Research (SBIR) Phase I contract by the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) for the development of medical Large Language Models (LLMs) for infectious and immune-mediated diseases. The award, totaling $299,208 for one year, will be used for research and development of LLMs for automated named entity recognition (NER), relation extraction, and ontology metadata enrichment from free-text clinical notes.

A prevailing challenge in this field involves accurately linking identified entities from tables, columns, or individual data values and their relationships. With a lack of semantic data standards for tracking infectious diseases like tuberculosis, measles, influenza, COVID-19, and others, it’s difficult to accurately measure and study them. The ability to make sense of relevant information from different healthcare organizations, coding systems, and modalities of data is critical to better understand the spread of disease.

Another important component to advancement in the field is ensuring findability, accessibility, interoperability, and reusability (FAIR) of information among the scientific community. This enables researchers to easily discover pertinent information and use it to further improve the understanding and outcomes around infectious disease. As such, this project goes beyond creating new tools, with a focus on promoting the sharing of data across the medical community.

The John Snow Labs team will collaborate on this project with Nasia Safdar, MD, infectious disease physician at The University of Wisconsin Health and Christina Cuomo, PhD, Viatris Professor of Molecular Microbiology and Immunology at Brown University.

“This SBIR Phase I award from NIAID represents a significant milestone for John Snow Labs and our commitment to using AI to accelerate modern medicine,” said David Talby, CTO, John Snow Labs. “The development of Medical LLMs that researchers can use to address complex challenges in the measurement and tracking of infectious disease has the potential to mitigate the spread of disease and save lives.”

About John Snow Labs
John Snow Labs, the AI for healthcare company, provides state-of-the-art software, models, and data to help healthcare and life science organizations put AI to good use. Developer of Spark NLP, Healthcare NLP, the Healthcare GPT LLM, the Generative AI Lab No-Code Platform, and the Medical Chatbot, John Snow Labs’ award-winning medical AI software powers the world’s leading pharmaceuticals, academic medical centers, and health technology companies. Creator and host of The NLP Summit, the company is committed to further educating and advancing the global AI community.

About the Funding
This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. 75N93024C00010.

Contact
Gina Devine
John Snow Labs
gina@johnsnowlabs.com

First published on Wed, Sep 18, 2024

Liked what you read? That’s only the tip of the tech iceberg!

Explore our vast collection of tech articles including introductory guides, product reviews, trends and more, stay up to date with the latest news, relish thought-provoking interviews and the hottest AI blogs, and tickle your funny bone with hilarious tech memes!

Plus, get access to branded insights from industry-leading global brands through informative white papers, engaging case studies, in-depth reports, enlightening videos and exciting events and webinars.

Dive into TechDogs' treasure trove today and Know Your World of technology like never before!

Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.

Join The Discussion

Join Our Newsletter

Get weekly news, engaging articles, and career tips-all free!

By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.

  • Dark
  • Light